The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 14, 2020

Filed:

Nov. 08, 2016
Applicants:

Shenzhen University, Shenzhen, Guangdong, CN;

Shenzhen Kangjuzheng Pharmaceutical Technology Co., Ltd., Shenzhen, Guangdong, CN;

Inventors:

Guangyi Jin, Guangdong, CN;

Zhulin Wang, Guangdong, CN;

Attorney:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 473/18 (2006.01); A61K 31/519 (2006.01); C07K 1/107 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/519 (2013.01); C07D 473/18 (2013.01); C07K 1/107 (2013.01); C07K 14/70503 (2013.01);
Abstract

Compound I and a compound II as well as preparation methods therefor and use thereof are disclosed. A newly synthesized compound of formula I is capable of stimulating congenital immunity and cellular immunity for tumor resistance while greatly improving the antitumor effect of ethacrynic acid (EA), and thus an integrated synergistic anti-tumor dual-immunity drug design is explored. The immune response mechanism for resisting melanoma of the compound as shown in the formula I is demonstrated. A compound that is as shown in a formula II and is prepared from the compound of formula I and ROR1 by means of covalency markedly slows down the growth of subcutaneously transplanted mammary cancer tumor, such that the immune response mechanism, for treating the mammary cancer, of the compound as shown in the formula II is demonstrated.


Find Patent Forward Citations

Loading…